Please assess the completion status of the following clinical trial:

Trial Title: Use of Novel Prebiotic Fiber for Targeted Dietary Management of Irritable Bowel Syndrome (Nutrabiotix Phase II)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion - History~1. Between the ages of 18-75~2. Have recurrent abdominal pain or discomfort at least 3 days/month in the last 3 months~3. Have at least 2 of the following in the last 6 months:~   1. Improvement of abdominal pain or discomfort with defecation~  2. Onset of abdominal pain or discomfort associated with change in frequency of stool~  3. Onset of abdominal pain or discomfort associated with a change in form/appearance of stool~4. Symptom onset at least 6 months prior to screening date~5. Willing to take study supplement three times a day and willing to comply with all study procedures (i.e. swallow capsules)~6. Willing to stop taking over-the-counter laxatives after the 2 week screening period (Ex: ex-lax, senna, miralax, milk of magnesia)~   Inclusion - Screening Diary~7. Abdominal bloating/discomfort/pain (if either a, b, OR c is positive, then this meets the criteria for #7)~   1. A weekly average of worst abdominal bloating score of ≥ 3 during the screening period on a 0-10 numeric rating scale~  2. A weekly average of worst abdominal discomfort score of ≥ 3 during the screening period on a 0-10 numeric rating scale~  3. A weekly average of worst abdominal pain score of ≥ 3 during the screening period on a 0-10 numeric rating scale~8. Bowel movements/stool consistency (if either a OR b is positive, then this meets the criteria for #8)~   1. Less than 3 spontaneous complete BM (SCBM) per week. (SCBM is defined as a BM occurring in the absence of a laxative that is associated with a sense of complete evacuation)~  2. Stool consistency of 1-2 on Bristol scale at least twice a week OR \>25% of BM for the week~Exclusion- Lab Results~1. Abnormalities in CBC (Hgb\<12 g/dL, platelet count\<100000, WBC\<4000 or \>10000)~2. Abnormal liver function tests (ALT, AST, alkaline phosphatase, or bilirubin \>1.5 times normal range)~3. Abnormal renal function tests (BUN or creatinine \>1.5 times normal range)~4. Low serum albumin (\<3 g/dL)~5. Uncontrolled thyroid disease as evident from abnormal TSH level~6. High CRP (\> 5), except those evaluated for IBD and IBD is ruled out through colonoscopy, CT or additional tests~7. Insulin-requiring and/or poorly controlled diabetes (well-controlled diabetics with HbA1c \<7 may be enrolled)~   Exclusion- History~8. Patient history of GI diseases (except for hemorrhoids or occasional (\<3 times a week) heartburn)~   1. Inflammatory bowel disease (Ex: ulcerative colitis, crohn's disease, any colitis)~  2. Celiac disease~  3. Colonic inertia (lazy/slow colon resulting in surgery, resection or daily laxatives)~  4. Diverticular stricture (narrowing of the colon)~9. Antibiotic use within last 4 weeks~10. Severe uncontrolled hypertension~11. Significant uncompensated cardiac or respiratory diseases (defined as requiring daily medication for management of their diseases (Ex: on oxygen or can't walk))~12. Prior extensive intestinal resection~13. History of psychiatric hospitalization OR suicide attempt in the last 5 years~14. Drug and/or alcohol abuse~15. Plan to have a major change of their dietary habit during the following 5 months~16. Drug induced constipation (Ex: opiates)~17. Pregnant or lactating~18. Use of narcotic medications (pain killers, Ex: hydrocodone, methadone, morphine, oxycodone or tramadol) or anticoagulant/antiplatelet agents (ex: heparin, warfarin , dabigitran., Coumadin)~19. If the subject is older than 50 years of age, subjects who have not had a colonoscopy within last 7 years or CT colonography within last 5 years to rule out colon cancer~20. Alarm symptoms of colon cancer such as:~    1. Weight loss (\>10% unintentional loss of body weight in last 6 months)~   2. Blood in the stool (except for clearly documented hemorrhoidal bleed OR colonoscopy excluding colon cancer within the last year for blood in the stool)~   3. Anemia (without a full work-up, including a colonoscopy or other tests deemed important)~21. Continued chronic and daily use of prescription laxatives (Ex: Amitiza or Linzess/ linaclotide in the last month)~22. Loose or watery stools \> than 3 times per week~23. History of fecal impaction requiring disimpaction in the last 3 months~24. History of laxative abuse (Ex: eating disorders)~25. Use of medications that affect gastrointestinal motility (i.e. resolor, domperidone, reglan, cisapride, anticolonergic drugs, tricyclic antidepressant \[Ex: Amitriptyline, Amoxapine, anafranil, asendin, elavil, norpramin/desipramine, doxepin, pamelor/nortriptyline, sinequan, surmontil/trimipramine, tofranil/imipramine or vivactil/protriptyline\]) SSRI's are OK~26. Documented untreated pelvic floor dysfunction~27. Colonic organic diseases such as:~    1. Current colonic cancer or strictures~   2. Connective tissue disease (ex: scleroderma, lupus)~   3. Other neurological disorders leading to chronic constipation (Ex: Parkinson's or multiple sclerosis)~28. Dietary intake exceptionally high in plant-based, high fiber foods, including those following a strict vegetarian diet (high fiber foods: fruits, vegetables, beans, whole grains, fortified foods)~29. Consumption of probiotics, prebiotics, or synbiotics without an appropriate 2-week washout period (Ex: Activia, FiberOne products, probiotics supplements such as Align, Pearls, or fiber/prebiotic supplements such as Metamucil, Benefiber, Citrucel, Fiber Choice, Fiber Powder)~30. Intention of using fiber products during the study (other than the study supplement)~31. Known food allergies or hypersensitivities (Ex: the components of psyllium or NTX-1 (corn))~32. Have a colonoscopy done within the next 5 months~Exclusion- Screening Diary 32. Use of laxatives more than twice in the screening period (The following are the ONLY laxatives the subject is allowed to use during the screening period: Ex-lax, senna, miralax and milk of magnesia) 33. Have not completed 11 out of 14 days of symptoms diary at screening 34. Have an average daily IBS-C global symptom score of \<2 in the screening period 35. Average Bristol stool scale of more than 4 within the screening period 36. Loose or watery stools with Bristol stool scale of 5 or greater for a total of 6 or more days during the screening period 37. Use of fiber products during the screening period

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- NTX-1 (Type: EXPERIMENTAL): NTX-1 (18 g)
- Psyllium (Type: ACTIVE_COMPARATOR): psyllium (15 g)

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: terminate
termination_type: safety issues